Jay Parekh, MD
NOTE : If you're an existing patient, please connect via MyChart
-
About Me
About Jay Parekh, MD
Jay Parekh, MD, is a medical oncologist specializing in gastrointestinal (GI) cancers at Mays Cancer Center. He is also an assistant professor in the Division of Hematology and Oncology at The University of Texas at San Antonio. Dr. Parekh cares for patients with cancers of the gastrointestinal system and provides medical treatment tailored to each patient’s diagnosis and treatment needs.
His clinical and research interests include gastrointestinal cancers, early-phase clinical trials and the development of new treatment approaches for solid tumors.
Dr. Parekh earned his medical degree from Lokmanya Tilak Municipal Medical College in Mumbai, India. He completed his internal medicine residency at Bridgeport Hospital/Yale New Haven Health, where he later served as chief resident. He then completed his hematology and oncology fellowship at UT Health San Antonio and joined the faculty in 2026.
He is a member of the American College of Physicians, American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research and SWOG Cancer Research Network.
Gender
- Male
Languages Spoken
- English
- Hindi
- Gujarati
- Marathi
-
Credentials
Credentials
Positions
- Assistant Professor, Division of Hematology and Oncology, The University of Texas at San Antonio
- Gastrointestinal Medical Oncologist, UT Health San Antonio MD Anderson Cancer Center
Education
- Medical School: Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India
- Fellowship: Hematology and Oncology, The University of Texas San Antonio Health Science Center, San Antonio, Texas
- Residency: Internal Medicine, Bridgeport Hospital/Yale New Haven Health, Bridgeport, Connecticut
- Chief Residency: Internal Medicine, Bridgeport Hospital/Yale New Haven Health, Bridgeport, Connecticut
- Locations & Contact
-
Research & Publications
Research & Publications
First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies
Mahadevan D, Barve M, Mahalingam D, Parekh J, Kurman M, Strauss J, Tremaine L, Hromas R, Sills J, McCulloch J, Harkey J, Suberg S, Zimmerman L, Zheng G, Zhou D.
Accelerated Aging in Cancer and Cancer Treatment: Current Status of Biomarkers
Abraham S, Parekh J, Lee S, Afrin H, Rozenblit M, Blenman KRM, Perry RJ, Ferrucci LM, Liu J, Irwin ML, Lustberg M.
A Rare Case of Autoimmune Hemolytic Anemia in Pancreatic Adenocarcinoma
Abraham S, Sultana S, Parekh J.
-
Clinical Trials
Clinical Trials
No Clinical Trials